The New Equivocal: Changes to HER2 FISH Results When Applying the 2013 ASCO/CAP Guidelines

Human epidermal growth factor receptor 2 (HER2, ERBB2) testing is an important prognostic/predictive marker in breast cancer management, especially in selecting HER2-targeted treatment. American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines address HER2 status...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of clinical pathology 2015-08, Vol.144 (2), p.253-262
Hauptverfasser:	Long, Thomas H, Lawce, Helen, Durum, Connie, Moore, Stephen R, Olson, Susan B, Gatter, Ken, Troxell, Megan L
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers, Tumor - analysis Breast Neoplasms Female Humans In Situ Hybridization, Fluorescence - standards Pathology, Molecular - standards Practice Guidelines as Topic - standards Receptor, ErbB-2 - analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!